ANI Pharmaceuticals says its 108-patient SYNCHRONICITY study met both six-month endpoints, with vision and retinal ...

Bristol Myers Squibb says 60 mg admilparant met the Phase 3 IPF endpoint, while 120 mg missed significance; companion data ...

Tialis Essential IT plc wins a five-year £7.6M utilities contract and renews a public-sector agreement generating about £1.2M ...

Maas reports A$373M paid against A$1.1B of Firmus work orders, with completion expected by end-2027 as its customer seeks ...

Ballard Mining has A$45 million in placement commitments at A$0.66 a share, plus a retail offer to fund Mt Ida drilling and ...

Nordic Resources reports 1.52 million gold-equivalent ounces at Kopsa, with 86 per cent measured and indicated and further ...

InnoCare says China approved its ICP-B161 IND, making it the fifth candidate to enter clinical development in 2026; ...

Cobre reports a 62.86 per cent interest in Sierra Atacama after exercising a control option for approximately US$12 million ...

Trulieve's Oct. 11 post says all locations are open; its linked customer page carries Oct. 9 closing notices for 13 Florida ...

NexGen says its Rook I freeze plant is preparing to ship for temporary ground freezing above basement rock that begins 100 ...

Roche says vamikibart gains lasted through week 52 in two UME trials as the FDA reviews an application for a decision by July ...

NexGen says Rook I's concrete batch plant arrived early during a planned four-year build; the update gave no commissioning or ...